Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease.

[1]  M. Aschner,et al.  Role of manganese in neurodegenerative diseases. , 2011, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[2]  H. Schiöth,et al.  Long evolutionary conservation and considerable tissue specificity of several atypical solute carrier transporters. , 2011, Gene.

[3]  J. Chalela,et al.  Manganese Encephalopathy: An Under-Recognized Condition in the Intensive Care Unit , 2011, Neurocritical care.

[4]  K. Gordon,et al.  Manganese Toxicity in a Child With Iron Deficiency and Polycythemia , 2011, Journal of child neurology.

[5]  R. Butterworth.  Metal Toxicity, Liver Disease and Neurodegeneration , 2010, Neurotoxicity Research.

[6]  C. Urani,et al.  Regulation of metallothioneins and ZnT-1 transporter expression in human hepatoma cells HepG2 exposed to zinc and cadmium. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[7]  S. Masuda,et al.  Demonstration and Characterization of the Heterodimerization of ZnT5 and ZnT6 in the Early Secretory Pathway* , 2009, The Journal of Biological Chemistry.

[8]  Taiho Kambe,et al.  Identification of the Zn2+ Binding Site and Mode of Operation of a Mammalian Zn2+ Transporter* , 2009, The Journal of Biological Chemistry.

[9]  M. Bitner-Glindzicz,et al.  Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia—A new metabolic disorder , 2008, Journal of Inherited Metabolic Disease.

[10]  A. Stepens,et al.  A Parkinsonian syndrome in methcathinone users and the role of manganese. , 2008, The New England journal of medicine.

[11]  S. Fahn,et al.  Manganic encephalopathy due to “ephedrone” abuse , 2007, Movement disorders : official journal of the Movement Disorder Society.

[12]  D. Blaudez,et al.  Phylogenetic and functional analysis of the Cation Diffusion Facilitator (CDF) family: improved signature and prediction of substrate specificity , 2007, BMC Genomics.

[13]  N. Chu,et al.  The natural history of neurological manganism over 18 years. , 2007, Parkinsonism & related disorders.

[14]  A. Favier,et al.  Differential regulation of zinc efflux transporters ZnT-1, ZnT-5 and ZnT-7 gene expression by zinc levels: a real-time RT-PCR study. , 2004, Biochemical pharmacology.

[15]  A. Favier,et al.  In silico identification and expression of SLC30 family genes: An expressed sequence tag data mining strategy for the characterization of zinc transporters' tissue expression , 2004, BMC Genomics.

[16]  E. Delhaize,et al.  Genes Encoding Proteins of the Cation Diffusion Facilitator Family That Confer Manganese Tolerance Article, publication date, and citation information can be found at www.plantcell.org/cgi/doi/10.1105/tpc.009134. , 2003, The Plant Cell Online.

[17]  S. Gospe,et al.  Paraparesis, hypermanganesaemia, and polycythaemia: a novel presentation of cirrhosis , 2000, Archives of disease in childhood.

[18]  R. Palmiter,et al.  Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. , 1995, The EMBO journal.

[19]  M. Goldberg,et al.  Regulation of the erythropoietin gene , 1993, Blood.

[20]  H. Nazer,et al.  Wilson's Disease. , 1991, Annals of Saudi medicine.

[21]  D B Calne,et al.  Chronic manganese intoxication. , 1989, Archives of neurology.

[22]  J. Roth.  Homeostatic and toxic mechanisms regulating manganese uptake, retention, and elimination. , 2006, Biological research.

[23]  S. Fahn.  Unified Parkinson's Disease Rating Scale , 1987 .

[24]  S. Fahn.  Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .